J.G.Chemicals Limited has informed the Exchange regarding Board meeting held on August 11, 2025.
JGCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
J.G.Chemicals' board approved its Q1 FY26 (quarter ended June 30, 2025) unaudited results. On a consolidated basis, revenue from operations rose about 8% year-on-year to ₹2,180.13 million, with net profit at ₹163.59 million versus ₹159.03 million in Q1 FY25. On a standalone basis, net profit jumped roughly 66% YoY to ₹63.67 million on revenue of ₹709.66 million, with EPS at ₹1.62 versus ₹0.98. The board also approved a ₹100 crore capex for a new zinc chemicals facility in Dahej, Gujarat, which will add 40,000 MT per annum of capacity (around 57% increase over the existing 69,984 MT) and is expected to generate ₹900 crore in future revenue, with Phase 1 starting in H1 FY27. The project will be funded entirely through internal accruals. Additionally, the board approved a ₹25,000 remuneration for M/s D. Banerjee & Associates as Cost Auditor for FY25-26.
The strong double-digit standalone profit growth and the debt-free capacity expansion plan signal healthy operational momentum and a clear long-term growth path. The Dahej project is a significant capacity boost, but since Phase 1 only begins in H1 FY27, the revenue benefit is roughly 1.5–2 years away, which may temper near-term excitement.